Meanwhile, aptamer-siRNA enabled efficient targeted delivery and gene silencing, resulting in robust CD47 knockdown and decreased CD47 surface expression in tumor-infiltrating Treg cells, as confirmed by qPCR and flow cytometry (Fig. 1f-g). The gene discussed is CD47; the disease is neoplasm.